Table 1 Descriptive analysis of the studied variables in controls and in subjects with liver steatosis
From: Increased serum levels of lipogenic enzymes in patients with severe liver steatosis
Controls (n=21) | Mild Steatosis (n=33) | Moderate Steatosis (n=38) | Severe Steatosis (n=23) | P value⁁° | ContrastsP value§ | |
|---|---|---|---|---|---|---|
Sex | 0.36 | |||||
male (%) | 12 (57.2%) | 6 (18.2) | 9 (23.7) | 8 (34.8) | ||
female (%) | 9 (42.8%) | 27 (81.8) | 29 (76.3) | 15 (65.2) | ||
Age (years) | 44.2±10.5 | 54.9±10.7 | 53.1±12.3 | 49.8±11.5 | 0.37 | |
BMI (kg/m2) | 25.2±4.1 | 32.1±3.3 | 31.6±4.8 | 34.7±5.4 | 0.02 | Mild vs Severe |
0.001* | P= 0.03 | |||||
Moderate vs Severe P= 0.01 | ||||||
HOMA index | 1.3±0.9 | 3.2±1.5 | 3.5±1.9 | 7.03±14.0 | 0.04 | Mild vs Severe |
0.001* | P= 0.018 | |||||
Moderate vs Severe P= 0.07 | ||||||
FAS (ng/ml) | 10.6±7.6 | 12.4±17.2 | 19.3±15.3 | 22.1±20.3 | 0.005 | Mild vs Moderate |
0.02* | P= 0.007 | |||||
Mild vs Severe | ||||||
P= 0.004 | ||||||
Severe vs Controls | ||||||
P= 0.005 | ||||||
LPL activity (pmol/min/ml) | 29.4±2.6 | 34.1±4.8 | 36.6±3.0 | 65.1±8.3 | 0.001 | Controls vs Severe |
0.07* | P= 0.003 | |||||
Mild vs Severe | ||||||
P= 0.002 | ||||||
Moderate vs Severe | ||||||
P= 0.003 |